Whelix offers AI-powered robotic platforms designed for end-to-end cell culture automation. Their systems automate routine tasks such as feeding, passaging, imaging, and plating to boost throughput, consistency, and research speed across life science workflows. The technology combines AI-guided planning, digital twins, computer vision, and autonomous decision-making to operate with minimal human intervention, enabling scalable, hands-free cell production in autonomous labs. Located in the life sciences automation space, Whelix integrates with existing lab infrastructure to transform traditional cell culture into a digitally coordinated, autonomous process.
No recent deals for this company.